title: Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.
abstract: Psoriasis is a chronic inflammatory disease affecting 2% to 3% of the population in Western countries. Psoriasis is associated with limited quality of life, cardiovascular disease, and depression. The approval of injectable biological agents has revolutionized the management of moderate to severe psoriasis. Adalimumab is a human monoclonal antibody against tumor necrosis factor (TNF) alpha approved for moderate-to-severe plaque-type psoriasis and psoriatic arthritis (PsA). This systematic review summarizes the evidence concerning the efficacy, clinical effectiveness, safety, and cost-effectiveness of adalimumab in the treatment of psoriasis. Five randomized controlled trials demonstrated the efficacy of adalimumab in moderate-to-severe plaque-type psoriasis and PsA with PASI-75 response rates of 53% to 80% and ACR-20 response rates of 39% to 58% after 12 to 16 weeks of treatment. In clinical practice patients who have not responded to one TNF antagonist may respond to another TNF antagonist. Adalimumab has similar or better cost-effectiveness than other biologics, but is less efficient than methotrexate and cyclosporine. Adalimumab is generally well tolerated. Patients should be evaluated for active/latent tuberculosis, serious infections, and other contraindications prior to initiation of adalimumab therapy. Future studies should investigate the comparative efficacy of adalimumab and other biologic and prebiologic agents. Recently established registries will yield additional data on the effectiveness and long-term safety of adalimumab.
authors.affiliation: Department of Dermatology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Germany. jochen.schmitt@uniklinkum-dresden.de
authors.forename: Jochen
authors.initials: J
authors.lastname: Schmitt
authors.forename: Gottfried
authors.initials: G
authors.lastname: Wozel
references.citation: Lancet. 2008 May 17;371(9625):1675-84
references.pmid: 18486740
references.citation: J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1105-6
references.pmid: 17714134
references.citation: Vaccine. 2003 Jul 28;21(24):3365-9
references.pmid: 12850341
references.citation: Clin Exp Dermatol. 2007 Sep;32(5):593-4
references.pmid: 17692063
references.citation: J Investig Dermatol Symp Proc. 2004 Mar;9(2):136-9
references.pmid: 15083780
references.citation: Br J Dermatol. 2009 Jun;160(6):1264-72
references.pmid: 19120346
references.citation: J Eur Acad Dermatol Venereol. 2008 Mar;22(3):380-2
references.pmid: 18269613
references.citation: Clin Exp Immunol. 1993 Nov;94(2):354-62
references.pmid: 8222328
references.citation: J Immunol. 2005 Jul 1;175(1):5-14
references.pmid: 15972624
references.citation: J Dermatolog Treat. 2008;19(3):185-7
references.pmid: 18569276
references.citation: Int Immunopharmacol. 2002 Apr;2(5):653-72
references.pmid: 12013505
references.citation: Rheumatology (Oxford). 2007 Jan;46(1):93-6
references.pmid: 16720636
references.citation: Arthritis Rheum. 1995 Jun;38(6):727-35
references.pmid: 7779114
references.citation: Eur J Epidemiol. 2004;19(3):225-30
references.pmid: 15117115
references.citation: J Rheumatol. 2007 May;34(5):1040-50
references.pmid: 17444593
references.citation: Expert Opin Drug Saf. 2005 Jul;4(4):637-41
references.pmid: 16011443
references.citation: Lancet. 2007 Jul 21;370(9583):263-271
references.pmid: 17658397
references.citation: Exp Dermatol. 2004 Apr;13(4):193-222
references.pmid: 15086336
references.citation: Dermatology. 2008;216(3):260-70
references.pmid: 18187944
references.citation: Arch Dermatol. 2006 Feb;142(2):198-202
references.pmid: 16490847
references.citation: J Am Acad Dermatol. 2008 Jan;58(1):125-35
references.pmid: 17996329
references.citation: Arthritis Rheum. 2008 Jul 15;59(7):996-1001
references.pmid: 18576309
references.citation: J Invest Dermatol. 1997 Oct;109(4):562-5
references.pmid: 9326391
references.citation: Neurology. 1999 Aug 11;53(3):457-65
references.pmid: 10449104
references.citation: Ann Rheum Dis. 2008 May;67(5):710-2
references.pmid: 18079191
references.citation: Am J Clin Dermatol. 2008;9(1):1-14
references.pmid: 18092839
references.citation: Arthritis Rheum. 2005 Oct;52(10):3279-89
references.pmid: 16200601
references.citation: Arthritis Rheum. 2001 Dec;44(12):2862-9
references.pmid: 11762947
references.citation: Dermatol Ther. 2004;17(5):427-31
references.pmid: 15379777
references.citation: Ann Rheum Dis. 1999 Nov;58 Suppl 1:I70-2
references.pmid: 10577977
references.citation: Ann Rheum Dis. 2009 Dec;68(12):1863-9
references.pmid: 19147611
references.citation: Nat Rev Drug Discov. 2003 Sep;2(9):736-46
references.pmid: 12951580
references.citation: J Am Acad Dermatol. 2008 Aug;59(2):209-17
references.pmid: 18485527
references.citation: Lancet. 2007 Jul 21;370(9583):272-284
references.pmid: 17658398
references.citation: Clin Rheumatol. 2007 Feb;26(2):261-4
references.pmid: 16924392
references.citation: J Am Acad Dermatol. 2008 Jan;58(1):106-15
references.pmid: 17936411
references.citation: Exp Dermatol. 2007 Oct;16(10):779-98
references.pmid: 17845210
references.citation: Clin Exp Dermatol. 1994 May;19(3):210-6
references.pmid: 8033378
references.citation: J Rheumatol. 2006 Jul;33(7):1447-51
references.pmid: 16724367
references.citation: Med Care. 1993 Mar;31(3):247-63
references.pmid: 8450681
references.citation: Br J Dermatol. 2007 Dec;157(6):1273-4
references.pmid: 17916219
references.citation: Dermatologica. 1978;157(4):238-44
references.pmid: 357213
references.citation: Br J Dermatol. 2008 Jul;159(1):257-8
references.pmid: 18489593
references.citation: Pharmacol Ther. 2008 Feb;117(2):244-79
references.pmid: 18155297
references.citation: Arthritis Rheum. 2007 Feb;56(2):476-88
references.pmid: 17265483
references.citation: Drugs Today (Barc). 2005 Jan;41(1):37-53
references.pmid: 15753968
references.citation: Transplantation. 1996 Mar 15;61(5):715-21
references.pmid: 8607173
references.citation: J Cutan Med Surg. 2009 Jan-Feb;13(1):48-50
references.pmid: 19298772
references.citation: Qual Life Res. 1993 Jun;2(3):169-80
references.pmid: 8401453
references.citation: Clin Dermatol. 2008 Sep-Oct;26(5):486-502
references.pmid: 18755367
references.citation: Arch Dermatol. 2007 Dec;143(12):1493-9
references.pmid: 18086997
references.citation: Br J Dermatol. 2008 Mar;158(3):558-66
references.pmid: 18047523
references.citation: Anal Biochem. 2001 Dec 15;299(2):119-29
references.pmid: 11730333
references.citation: J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):177-86
references.pmid: 10025742
references.citation: Arch Dermatol. 2008 Feb;144(2):200-7
references.pmid: 18283176
references.citation: Lancet. 2008 May 17;371(9625):1665-74
references.pmid: 18486739
references.citation: Br J Dermatol. 2008 Sep;159(3):513-26
references.pmid: 18627372
references.citation: Semin Cutan Med Surg. 2005 Mar;24(1):52-7
references.pmid: 15900799
references.citation: Clin Exp Immunol. 1994 Apr;96(1):146-51
references.pmid: 8149659
references.citation: J Rheumatol. 1998 Aug;25(8):1544-52
references.pmid: 9712099
references.citation: Chest. 2007 Jun;131(6):1898-906
references.pmid: 17565023
references.citation: JAMA. 2006 Oct 11;296(14):1735-41
references.pmid: 17032986
references.citation: Rheumatology (Oxford). 2007 Apr;46(4):695-8
references.pmid: 17158212
references.citation: J Am Acad Dermatol. 2005 Nov;53(5 Suppl 1):S260-2
references.pmid: 16227104
references.citation: J Am Acad Dermatol. 2007 Aug;57(2):347-54
references.pmid: 17433490
references.citation: J Dermatolog Treat. 2005;16(5-6):350-2
references.pmid: 16428160
references.citation: J Rheumatol. 1998 Jan;25(1):105-10
references.pmid: 9458212
references.citation: J Am Acad Dermatol. 2007 Aug;57(2):269-75
references.pmid: 17574299
references.citation: Am J Pathol. 1991 Jan;138(1):129-40
references.pmid: 1702929
references.citation: Br J Dermatol. 2007 Mar;156(3):486-91
references.pmid: 17300238
references.citation: J Am Acad Dermatol. 2008 Feb;58(2 Suppl):S50-2
references.pmid: 18191709
references.citation: J Am Acad Dermatol. 1991 May;24(5 Pt 1):675-85
references.pmid: 1869638
references.citation: Am J Respir Crit Care Med. 2006 Oct 1;174(7):736-42
references.pmid: 16799073
references.citation: Med Care. 1992 Jun;30(6):473-83
references.pmid: 1593914
references.citation: Arthritis Rheum. 2008 Feb 15;59(2):234-40
references.pmid: 18240258
references.citation: J Dermatolog Treat. 2007;18(1):25-31
references.pmid: 17365264
references.citation: Lancet. 2001 Sep 29;358(9287):1042-5
references.pmid: 11589933
references.citation: Br J Dermatol. 2008 Mar;158(3):549-57
references.pmid: 18047521
references.citation: Clin Exp Dermatol. 1994 Sep;19(5):383-7
references.pmid: 7955493
references.citation: Clin Ther. 2003 Jun;25(6):1700-21
references.pmid: 12860493
references.citation: J Am Acad Dermatol. 2002 Jun;46(6):850-60
references.pmid: 12063481
references.citation: J Am Acad Dermatol. 2007 May;56(5 Suppl):S65-7
references.pmid: 17434043
references.citation: Arch Dermatol. 2008 Jun;144(6):804-6
references.pmid: 18559778
references.citation: J Invest Dermatol. 1993 Nov;101(5):701-5
references.pmid: 7693825
references.citation: Ann Rheum Dis. 2009 May;68(5):702-9
references.pmid: 18684743
references.citation: Dermatol Online J. 2006 Feb 28;12(2):4
references.pmid: 16638397
references.citation: J Neurol Sci. 2006 May 15;244(1-2):133-6
references.pmid: 16527311
references.citation: J Dermatolog Treat. 2007;18(6):341-50
references.pmid: 18058494
references.citation: Dermatology. 2006;213(2):102-10
references.pmid: 16902286
references.citation: Arch Dermatol. 2006 Dec;142(12):1654-5
references.pmid: 17179003
references.citation: Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):121-8
references.pmid: 15180464
references.citation: Ann Rheum Dis. 2007 Feb;66(2):163-8
references.pmid: 17046964
references.citation: J Am Acad Dermatol. 2006 Oct;55(4):598-606
references.pmid: 17010738
references.citation: Exp Dermatol. 2003 Aug;12(4):460-5
references.pmid: 12930303
references.citation: J Biol Regul Homeost Agents. 1997 Jul-Sep;11(3):115-8
references.pmid: 9498161
references.citation: J Am Acad Dermatol. 2008 Jun;58(6):1073-5
references.pmid: 18485990
references.citation: N Engl J Med. 2003 Apr 24;348(17):1681-91
references.pmid: 12711744
references.citation: Am J Pathol. 1991 Mar;138(3):727-39
references.pmid: 1848044
references.citation: Dermatology. 2007;215(1):17-27
references.pmid: 17587835
references.citation: J Dtsch Dermatol Ges. 2006 Nov;4 Suppl 2:S1-126
references.pmid: 17187649
references.citation: Int J Dermatol. 1993 Mar;32(3):188-90
references.pmid: 8444530
references.citation: J Investig Dermatol Symp Proc. 2004 Mar;9(2):140-7
references.pmid: 15083781
references.citation: J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S38-41
references.pmid: 15253689
references.citation: Clin Infect Dis. 2006 Nov 15;43(10):e95-100
references.pmid: 17051484
references.citation: Arch Dermatol. 2008 Oct;144(10):1403-4
references.pmid: 18936418
references.citation: Nat Med. 2007 Mar;13(3):242-4
references.pmid: 17342112
references.citation: Health Qual Life Outcomes. 2008 Oct 02;6:75
references.pmid: 18831744
references.citation: Arthritis Rheum. 2005 Sep;52(9):2693-6
references.pmid: 16142749